FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jorunn Eyfjörd

Research Profile

Disorders

Genes & Molecular Sequences

Genes, p53

Geographic Areas

Iceland

Physiology

Chemicals & Drugs

Anatomy

Chromosomes, Human, Pair 17

Procedures

Living Beings

Heterozygote

Concepts & Ideas

Pedigree

Co-author Network

Publications

TOP 3
S Harlid; Kari Hemminki; M I L Ivarsson; P Lenner; J Manjer; Joakim Dillner; Jorunn E Eyfjörd; A Försti; E Grzybowska; S Butt; J Carlson
Combined effect of low-penetrant SNPs on breast cancer risk.
Sophia Harlid; Malin I L Ivarsson; Per Lenner; Jonas Manjer; Salma Butt; Joakim Dillner; Jorunn E Eyfjörd; Joyce Carlson
Interactive effect of genetic susceptibility with height, body mass index, and hormone replacement therapy on the risk of breast cancer.
Hong Shi; Karolina Tecza; Melanie Bevier; Andreas Brandt; Dorota Butkiewicz; Joyce Carlson; Bowang Chen; Kerstin Enquist; Jorunn E Eyfjörd; Ewa Grzybowska; Ute Hamann; Kari Hemminki; Roger Henriksson; Stefan Herms; Per Hoffmann; Robert Johansson; Jesús Lascorz; Per Lenner; Jonas Manjer; Jolanta Pamula-Pilat; Asta Försti
Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jorunn Eyfjörd (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: S Harlid; Kari Hemminki; M I L Ivarsson; P Lenner; J Manjer; Joakim Dillner; Jorunn E Eyfjörd; A Försti; E Grzybowska; S Butt; J Carlson
Combined effect of low-penetrant SNPs on breast cancer risk.
British journal of cancer 2012;106(2):389-96.
2012: Sophia Harlid; Malin I L Ivarsson; Per Lenner; Jonas Manjer; Salma Butt; Joakim Dillner; Jorunn E Eyfjörd; Joyce Carlson
Interactive effect of genetic susceptibility with height, body mass index, and hormone replacement therapy on the risk of breast cancer.
BMC women's health 2012;12():17.
2011: Hong Shi; Karolina Tecza; Melanie Bevier; Andreas Brandt; Dorota Butkiewicz; Joyce Carlson; Bowang Chen; Kerstin Enquist; Jorunn E Eyfjörd; Ewa Grzybowska; Ute Hamann; Kari Hemminki; Roger Henriksson; Stefan Herms; Per Hoffmann; Robert Johansson; Jesús Lascorz; Per Lenner; Jonas Manjer; Jolanta Pamula-Pilat; Asta Försti
Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome.
Breast cancer research and treatment 2011;130(3):905-16.
2011: Margret Steinarsdottir; Elinborg J Olafsdottir; Jorunn E Eyfjörd; Ingi Hrafn Gudmundsson; Jon Gunnlaugur Jonasson; Helga M Ogmundsdottir
Cytogenetic polyclonality of breast carcinomas: association with clinico-pathological characteristics and outcome.
Genes, chromosomes & cancer 2011;50(11):930-9.
2010: Asta Björk Jonsdottir; Roeland W Dirks; Johannes Vrolijk; Helga M Ogmundsdottir; Hans J Tanke; Jorunn E Eyfjörd; Karoly Szuhai
Centriole movements in mammalian epithelial cells during cytokinesis.
BMC cell biology 2010;11():34.
2009: Asta Björk Jonsdottir; Maaike P G Vreeswijk; Ron Wolterbeek; Peter Devilee; Hans J Tanke; Jorunn E Eyfjörd; Karoly Szuhai
BRCA2 heterozygosity delays cytokinesis in primary human fibroblasts.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2009;31(3):191-201.
2007: Sigríthur K Bodvarsdóttir; Margrét Steinarsdóttir; Hólmfríthur Hilmarsdóttir; Jón Gunnlaugur Jónasson; Jorunn E Eyfjörd
MYC amplification and TERT expression in breast tumor progression.
Cancer genetics and cytogenetics 2007;176(2):93-9.
2006: Laufey Tryggvadottir; Helgi Sigvaldason; Gudridur H Olafsdottir; Jon G Jonasson; Thorvaldur Jonsson; Hrafn Tulinius; Jorunn E Eyfjörd
Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.
Journal of the National Cancer Institute 2006;98(2):116-22.
2000: Steinthor Sigurdsson; S K Bödvarsdottir; K Anamthawat-Jonsson; Margret Steinarsdottir; Jon G Jonasson; Helga M Ogmundsdottir; Jorunn E Eyfjörd
p53 abnormality and chromosomal instability in the same breast tumor cells.
Cancer genetics and cytogenetics 2000;121(2):150-5.
1999: HJ van Slooten; Marc J van de Vijver; A L Borresen; Jorunn E Eyfjörd; Rut Valgardsdottir; Siegfried Scherneck; J M Nesland; Peter Devilee; Cees J Cornelisse; Jan Hein van Dierendonck
Mutations in exons 5-8 of the p53 gene, independent of their type and location, are associated with increased apoptosis and mitosis in invasive breast carcinoma.
The Journal of pathology 1999;189(4):504-13.
1998: Steinunn Thorlacius; Jeffery Struewing; P Hartge; Gudridur H Olafsdottir; Helgi Sigvaldason; Laufey Tryggvadottir; S Wacholder; Hrafn Tulinius; Jorunn E Eyfjörd
Population-based study of risk of breast cancer in carriers of BRCA2 mutation.
Lancet 1998;352(9137):1337-9.
1998: Jorunn E Eyfjörd; Helga M Ogmundsdottir; G Eggertsson; T Zoëga
deCODE deferred.
Nature biotechnology 1998;16(6):496.
1998: Sigridur Klara Bödvarsdóttir; Steinthor Sigurdsson; M Steinarsdóttir; Jorunn E Eyfjörd; Helga M Ogmundsdóttir; Kesara Anamthawat-Jónsson
Simultaneous detection of p53 nuclear protein and chromosome aberrations on sections from formalin-fixed, paraffin-embedded breast cancer tissue.
Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology 1998;6(3):233-5.
1998: J Chen; Mia Hedman; B W Arver; Steinthor Sigurdsson; Jorunn E Eyfjörd; Annika Lindblom
BRCA2 germline mutations in Swedish breast cancer families.
European journal of human genetics : EJHG 1998;6(2):134-9.
1998: CM Phelan; Ake Borg; Marguerite Cuny; DN Crichton; T Baldersson; T I Andersen; MA Caligo; Rosette Lidereau; Annika Lindblom; S Seitz; D Kelsell; U Hamann; P Rio; S Thorlacius; Janos Papp; Edith Olah; Bruce A J Ponder; Y J Bignon; Siegfried Scherneck; Rosa B Barkardottir; A L Borresen-Dale; Jorunn E Eyfjörd; Charles Theillet; Alastair Thompson; Catharina Larsson
Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
Cancer research 1998;58(5):1004-12.
1998: S Gretarsdottir; Steinunn Thorlacius; Rut Valgardsdottir; Sigfridur Gudlaugsdottir; Steinthor Sigurdsson; Margret Steinarsdottir; Jon G Jonasson; K Anamthawat-Jonsson; Jorunn E Eyfjörd
BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability.
Cancer research 1998;58(5):859-62.
1997: Steinthor Sigurdsson; Steinunn Thorlacius; J Tomasson; Laufey Tryggvadottir; Kristrun R Benediktsdottir; Jorunn E Eyfjörd; Eirikur Jonsson
BRCA2 mutation in Icelandic prostate cancer patients.
Journal of molecular medicine (Berlin, Germany) 1997;75(10):758-61.
1997: Steinunn Thorlacius; Steinthor Sigurdsson; Helga Bjarnadottir; Gudridur H Olafsdottir; Jon G Jonasson; Laufey Tryggvadottir; Hrafn Tulinius; Jorunn E Eyfjörd
Study of a single BRCA2 mutation with high carrier frequency in a small population.
American journal of human genetics 1997;60(5):1079-84.
1997: Peter Devilee; J Hermans; Jorunn E Eyfjörd; A L Bøorresen; Rosette Lidereau; H Sobol; Ake Borg; Anne-Marie Cleton-Jansen; Edith Oláh; B B Cohen; Siegfried Scherneck; U Hamann; B Peterlin; MA Caligo; Y J Bignon; Christine Maugard
Loss of heterozygosity at 7q31 in breast cancer: results from an International Collaborative Study Group. The Breast Cancer Somatic Genetics Consortium.
Genes, chromosomes & cancer 1997;18(3):193-9.
1997: Rut Valgardsdottir; Laufey Tryggvadottir; Margret Steinarsdottir; Kristrun Olafsdottir; S Jonasdottir; Jon G Jonasson; Helga M Ogmundsdottir; Jorunn E Eyfjörd
Genomic instability and poor prognosis associated with abnormal TP53 in breast carcinomas. Molecular and immunohistochemical analysis.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1997;105(2):121-30.
1996: Rut Valgardsdottir; Margret Steinarsdottir; K Anamthawat-Jonsson; I Petursdottir; Helga M Ogmundsdottir; Jorunn E Eyfjörd
Molecular genetics and cytogenetics of breast carcinomas: comparison of the two methods.
Cancer genetics and cytogenetics 1996;92(1):37-42.
1996: S Gretarsdottir; Laufey Tryggvadottir; Jon G Jonasson; Haraldur Sigurdsson; K Olafsdottir; Bjarni A Agnarsson; Helga M Ogmundsdottir; Jorunn E Eyfjörd
TP53 mutation analyses on breast carcinomas: a study of paraffin-embedded archival material.
British journal of cancer 1996;74(4):555-61.
1996: Steinunn Thorlacius; G Olafsdottir; Laufey Tryggvadottir; Susan L Neuhausen; Jon G Jonasson; Sean V Tavtigian; Hrafn Tulinius; Helga M Ogmundsdottir; Jorunn E Eyfjörd
A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes.
Nature genetics 1996;13(1):117-9.
1996: Kesara Anamthawat-Jónsson; Jorunn E Eyfjörd; Helga M Ogmundsdóttir; I Pétursdóttir; M Steinarsdóttir
Instability of chromosomes 1, 3, 16, and 17 in primary breast carcinomas inferred by fluorescence in situ hybridization.
Cancer genetics and cytogenetics 1996;88(1):1-7.
1995: Steinunn Thorlacius; B Thorgilsson; J Björnsson; Laufey Tryggvadottir; A L Börresen; Helga M Ogmundsdottir; Jorunn E Eyfjörd
TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis.
European journal of cancer (Oxford, England : 1990) 1995;31A(11):1856-61.
1995: A L Børresen; Tone Ikdal Andersen; Jorunn E Eyfjörd; R S Cornelis; Steinunn Thorlacius; Ake Borg; U Johansson; Charles Theillet; S Scherneck; S Hartman
TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains.
Genes, chromosomes & cancer 1995;14(1):71-5.
1995: M Steinarsdóttir; I Pétursdóttir; S Snorradóttir; Jorunn E Eyfjörd; Helga M Ogmundsdóttir
Cytogenetic studies of breast carcinomas: different karyotypic profiles detected by direct harvesting and short-term culture.
Genes, chromosomes & cancer 1995;13(4):239-48.
1995: Jorunn E Eyfjörd; Steinunn Thorlacius; Margret Steinarsdottir; Rut Valgardsdottir; Helga M Ogmundsdottir; K Anamthawat-Jonsson
p53 abnormalities and genomic instability in primary human breast carcinomas.
Cancer research 1995;55(3):646-51.
1995: Jorunn E Eyfjörd; Steinunn Thorlacius; Rut Valgardsdottir; S Gretarsdottir; Margret Steinarsdottir; K Anamthawat-Jonsson
TP53 abnormalities and genetic instability in breast cancer.
Acta oncologica (Stockholm, Sweden) 1995;34(5):663-7.
1993: Steinunn Thorlacius; A L Börresen; Jorunn E Eyfjörd
Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor.
Cancer research 1993;53(7):1637-41.
1992: Jorunn E Eyfjörd; Steinunn Thorlacius
Genetic changes in breast carcinomas in an Icelandic population.
Pharmacogenetics 1992;2(6):309-16.
1992: A L Børresen; Tone Ikdal Andersen; Judy E Garber; N Barbier-Piraux; Steinunn Thorlacius; Jorunn E Eyfjörd; L Ottestad; Birgitte Smith-Sørensen; Eivind Hovig; David Malkin
Screening for germ line TP53 mutations in breast cancer patients.
Cancer research 1992;52(11):3234-6.